Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study - Pohl, E.; Schneeweiss, A.; Hauke, J.; Moebus, V.; Furlanetto, J.; Denkert, C.; Fasching, Peter; Hanusch, C.; Tesch, H.; Weber-Lassalle, N.; Mueller, V.; Rhiem, K.; et al. (ANNALS OF ONCOLOGY, 2018)
CRIS-Team WoS Importer:2019-03-08